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Introduction
Investigations of metabolism in health and disease increas-
ingly rely on tracing the use of stable isotope-enriched nutrients 
through the cells metabolic pathways. The most widely utilised 
technology platform to analyse the resulting complex patterns 
of labelling in multiple cellular metabolites is mass spectrom-
etry (MS), due to its high sensitivity, short run times and a result-
ing low-cost operation1–12. Conversely, NMR spectroscopy is 
relatively under-utilised, despite being able to provide higher 
resolution information on the conversion of synthetically pro-
duced stable isotopes of nutrients are incorporated into cellular 
metabolites12–19. This is because this platform has historically 
suffered from low sensitivity, long acquisition times and the need 
for complex analytical tools.
NMR spectroscopy is, however, ideally suited to answering 
some of the more pressing questions about metabolic control in 
health and disease. We currently have limited knowledge about 
the compartmentalisation of metabolic pathways in metabolically-
active organelles, such as mitochondria, and therefore whether 
the same metabolite is selectively utilised for distinct purposes 
in different compartments. Given the recent drive to target metab-
olism in various diseases, understanding the control of metabo-
lism by different tissues is critical to the ability to select specific 
therapies which target the desired pathways within appropriate 
cellular compartments.
Stable isotope-enriched metabolic precursors, such as glucose or 
glutamine, are employed as metabolic tracers. These synthetically 
produced nutrients are enriched in isotopes with a low natural 
abundance, such as 13C or 15N. Despite the fact that metabolites 
can arise from multiple sources, the contribution of the different 
metabolic pathways to the synthesis of this metabolite can be 
determined through the analysis of the 13C and/or 15N distribution 
within the metabolite (Figure 1).
Our recently published combined NMR and MS approach 
(CANMS) harnesses the strengths of both modalities to produce 
highly-resolved metabolism information in the form of metabo-
lite isotopomers19. The detailed interpretation of MS isotopologue 
data, when using MS data in isolation, requires use of a pre-defined 
metabolic model. In contrast, the integrated analysis of NMR 
Figure 1. Tracing of metabolic pathways. The labelling patterns arising from [1,2-13C] glucose (A & B) as well as from [U-13C,15N] glutamine 
(C for 13C labelling and A-C for 15N labelling) are shown. Metabolism of [1,2-13C] glucose leads to distinctive labelling patterns in lactate 
and alanine ([2,3-13C] lactate/alanine when using glycolysis and [3-13C] lactate/alanine when using the pentose phosphate shunt, PPP) 
(Panel A). Similarly, glutamate and aspartate express different labelling patterns from [1,2-13C] glucose, depending whether they 
were synthesised via pyruvate dehydrogenase (PDH; resulting in [4,5-13C] glutamate) or via the pyruvate carboxylase (PC; resulting in 
[2,3-13C] aspartate) route (Panel B). Metabolisation of labelled glutamine can reveal other anaplerotic pathway activities such as reductive 
carboxylation (Panel C).
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and MS data makes fewer assumptions about the metabolic 
network, providing a more accurate insight into relative path-
way contributions than is possible with current established meth-
ods or the independent analysis of MS or NMR data alone. For 
example, proton-less carbon atoms do not give rise to a signal in 
2D-HSQC NMR spectra, although incomplete information on 
those carbons is available via splitting of adjacent carbon nucleus 
signals. The combination of NMR and MS analysis fills this gap 
as the MS data provides information on the amount of single 
carbon labelling into those carbon nuclei via “m+x” isotopo-
logues. [13C-1,2] glucose is the optimal tracer to assess metabolic 
flux through glycolysis vs pentose phosphate pathway (PPP) 
shunting back into glycolysis. While the glycolytically derived 
isotopomer of lactate is [13C-2,3] lactate, the PPP derived iso-
topomers can be [13C-3], [13C-1] or [13C-1,3] lactate. While the first 
isotopomer can be assessed with NMR data, the other two 
isotopomers include labelling in C(1), which HSQC NMR is 
“blind” to. In these cases, MS data adds new information to the 
NMR data by contributing the isotopologues NMR is not able to 
detect, while NMR adds to the MS data by differentiating between 
[13C-1,3] and [13C-2,3] lactate.
A major drawback of utilising 13C-13C scalar coupling informa-
tion to derive isotopomer distributions is the time required to 
acquire spectra. For example, around four hours are required for 
the acquisition of a high-resolution 2D-HSQC NMR sample, 
even when using fast, state-of-the-art non-uniform sampling (NUS) 
techniques.
Here we describe two novel developments, quantitative spectral 
filters and J-coupling enhancement, to facilitate and speed-
up the acquisition of NMR spectra for tracer based analysis of 
metabolism. Such techniques permit high throughput metabolic 
pathway profiling, increasing access, affordability and sensitiv-
ity when using NMR as an investigative modality. Additionally, 
these developments facilitate fast detection of 15N labelling, 
especially when combined with 13C tracing, thus providing 
the information required for more accurate metabolic pathway 
profiling.
Methods and results
Quantitative spectral filters for 13C tracer observation: 1D 
Spectral filters
Experimental setup. A porcine kidney (WIT-15 minutes) was 
procured from a slaughterhouse (FA Gill, Wolverhampton) 
following approximately 14 minutes warm ischaemia as per 
previous experimental methodology18. No animal was killed solely 
for experimental purposes; all were due for human consumption 
and therefore no ethical approval was required. After 2 hours 
cold ischaemic time, kidneys were subject to 18 hours of hypo-
thermic machine perfusion. The perfusate sample was collected 
after 6 hrs of perfusion and prepared for NMR analysis.
1D NMR spectra were acquired using a Bruker Avance III 
600 MHz NMR spectrometer equipped with a 5mm z-PFG TCI 
Cryoprobe. 128 transients were acquired for each spectrum with 
a 5 seconds interscan relaxation delay. A total of 32768 data 
points with a spectral width of 12ppm was acquired for each FID 
using Bruker’s adiabatic bi-level decoupling scheme to suppress 
1H,13C J-coupling during acquisition. Decoupling for this long 
(2.25s) was possible because of the cryogenic probe and will 
quite possibly lead to probe damage when using a NMR system 
equipped with a room temperature probe.
The spectra were processed within the MetaboLab software 
package (version 1.0.0.1)20. 0.5Hz line broadening was applied 
with zero-filling the data up to 131072 real data points prior to 
Fourier transformation. The resulting spectra were referenced 
using DSS and manually phase corrected. Subsequently the 
spectral baseline was corrected using MetaboLab’s spline base-
line correction before the spectra were exported to Bruker format 
for metabolites to be quantified in the Chenomx software package 
(version 8.2, http://www.chenomx.com).
NMR methodology. Despite their relative simplicity and limited 
resolution, 1D-NMR spectra are a highly sensitive tool to iden-
tify and quantify metabolites. Spectral filters enable the acquisi-
tion of spectra which filter out certain signals, thereby reducing 
ambiguity in 1D spectra associated with attributing peaks to nuclei 
within metabolites. For example, one can acquire 1D 1H NMR 
spectra of protons bound to 13C only, simplifying signal assign-
ment and analysis of the acquired spectra. The simplest approach 
to collect such spectra would be to acquire the first increment of a 
2D-1H,13C HSQC spectrum. However, signal intensities are not 
directly comparable with those in a standard 1D-1H NMR spec-
tra. It is therefore not possible to directly derive 13C percentages 
based on a comparison of those spectra with standard proton 1D 
spectra unless only a small subset of molecules is labelled with 
13C and one accompanying spectrum is scaled so that the major-
ity of signals within the two spectra are of same intensity21. Spec-
tral filters such as BIRD and TANGO22–25 originated in protein 
NMR spectroscopy to filter out certain parts of the magnetisation 
and therefore quantitative data cannot be gained from resultant 
output spectra. Quantitative comparisons between unfiltered and 
filtered spectra are usually unnecessary, except for tracer based 
analysis. Here we present a novel spectral filter which enables 
quantitative analysis of resultant spectra from single samples, 
enriched with 13C tracer.
Figure 2a shows the pulse sequences implementing the quantita-
tive spectral filter. While the grey shaded 13C π-pulse is used only 
in odd transients and replaced with a delay of the same length 
during even transients, the blue 13C π-pulses are only used in 
the 12C filtering experiment, where 1H magnetisation to 12C 
neighbours is filtered out, so that only 13C bound 1H magnetisa-
tion contributes to the signal intensities in the 1D spectrum. The 
phase cycle φ1 changes as well between the 2 experiments, as 
indicated by the same colour scheme (black: all protons, blue, 
13C bound protons only).
Figure 2b depicts two sample spectra from a perfusate sample 
where a cadaveric porcine kidney was perfused with modified 
University of Wisconsin machine perfusion solution (UW 
MPS) during a period of commonly used hypothermic machine 
perfusion. The standard unlabelled glucose constituent (10mM) 
within classical UW MPS was replaced with universally 
labelled glucose, at the same concentration, for use as a metabolic 
tracer.
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Figure 2. Spectral Filters in 1D spectroscopy. To determine percentage 13C incorporation two spectra are acquired per sample. One 
spectrum contains 1H signals originating from all protons (all 1H spectrum), while the second spectrum only contains signals from protons 
attached to a 13C nucleus. For the all 1H spectrum, the blue 13C 180 degree pulses are omitted. The grey shaded 13C pulse is executed every 
second transient in both experiments. The proton magnetisation in the all 1H pulse sequence is the same for 12C and for 13C bound protons 
and as a consequence, all 1H magnetisation is longitudinal during the interval between 1H pulses with the phases φ2 and φ4. Because of 
the additional 13C 180 degree pulses in the 13C bound 1H pulse sequence, the magnetisation for the two different kinds of protons develops 
differently. Here only the 13C bound 1H magnetisation is longitudinal in the interval between the 1H pulses with the phases φ2 and φ4. Therefore, 
the 12C bound 1H magnetisation can be destroyed using the two pulse field gradients labelled gp1 and gp2. The grey shaded 180 degree 13C 
pulse, which is only executed every second transient improves magnetisation selection as it is accompanied with phase changes of the 1H 
pulses and the receiver. All 13C π-pulses are adiabatic Chirp pulses with γB1max = Hz. The pulse phases are: φ1 = x, x, -x, -x; φ2 = x, x, -x, -x / y, y, 
-y, -y, φ3 = x, y, -x, -y, φ4 = x, -x, -x, x, y, -y, -y, y / y, -y, -y, y, -x, x, x, -x. The blue phases refer to the 13C bound 1H spectrum where applicable.
J-Coupling enhancement
Experimental setup. Slaughterhouse porcine kidneys (WIT-15 
minutes) were cannulated and flushed with chilled Soltran solu-
tion (Baxter) as performed in clinical practice. Kidneys were 
placed in static cold storage en route to our laboratory, where they 
were immediately perfused with KPS-1 using the Lifeport Kidney 
Transporter 1.0 (Organ Recovery Systems), which has been 
modified to include a paediatric oxygenator. Oxygen was supplied 
at a flow rate of 0.7L/min and perfusion time was 24 hours.
At experimental endpoint, the kidney was removed from the 
perfusion circuit and laterally bisected. Sections of cortex and 
medulla were isolated and snap frozen in liquid nitrogen. These 
tissues were powdered under liquid nitrogen, and 0.5g was placed 
in 7ml homogenisation tube (Precellys, CK28), containing 5.1 ml 
of HPLC grade methanol (−80°C) to quench metabolism. 
These were homogenised using the Precellys 24 dual homog-
eniser (8x 5000 rpm for 15 s). The samples were mixed with 
4.65 ml deionised water and 5.1ml HPLC grade chloroform and 
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vigorously agitated. Biphasic separation of polar and non-polar 
solvents was performed by centrifugation (1300g, 15 minutes, 
4°C), after which 4.5ml of the polar layer was aspirated and 
dried overnight at 35°C.
The dried extracts were re-suspended in 60 µl NMR buffer 
(0.1M phosphate buffer, 0.5mM 4,4-dimethyl-4-silapentane-1- 
sulfonic acid, 2mM imidazole and 10% D20). These suspensions 
were sonicated to dissolve micro particles and then 35 µl of this 
solution was added to 1.7mm NMR tubes.
2D 1H13C-HSQC NMR spectra were acquired using a Bruker 
Avance III 600 MHz NMR spectrometer equipped with a 
1.7mm z-PFG TCI Cryoprobe. The HSQC spectra were acquired 
using 2 transients per increment with echo/anti-echo gradient 
coherence selection and an additional pre-saturation for sup-
pressing the water resonance during the 1.5s interscan relaxation 
delay. The 1H dimension was acquired with a spectral width of 
13ppm using 512 complex data points. The 13C dimension was 
acquired with a spectral width of 160 ppm using 25% (2048) of 
8192 data points using a non-uniform sampling scheme. The 
non-uniformly sampled spectra were reconstructed via the 
compressed sensing algorithm within the MDDNMR (version 
2.5)26 and processed using NMRPipe (version 9.2)27. All 
spectra were processed without baseline correction to avoid 
complications in the multiplet analysis procedure.
NMR methodology. The relatively long acquisition times of 
2D-HSQC spectra are necessary to generate the spectral resolu-
tion required to resolve complex multiplet patterns19. Here we 
present a technique to manipulate the appearance of NMR multi-
plets in the indirect dimension of 2D-HSQC spectra. The ability 
to expand the splitting caused by J-coupling negates the require-
ment for the collection of large number of increments in the 
13C dimension. It also means that at increasingly higher mag-
netic fields, the advantages of extra sensitivity and increased 1H 
chemical shift resolution are not negated by the increased 13C 
increments needed in in order to resolve J-couplings. Increased 
J-coupling splitting can be achieved by incrementing the spin 
echo delay after the period where chemical shift of 13C evolves in 
parallel with the chemical shift evolution (Figure 3). This spin 
echo refocuses the 13C chemical shift and the 1H-13C coupling, but 
allows the 13C-13C coupling to evolve further. The delays in the 
spin echo are proportional to those in the Ω+JCC evolution period 
with the amount of extra coupling achieved being defined by the 
stretch of the JCC increment compared to the Ω+JCC incre-
ment. Thus, the 13C-13C J-couplings can be expanded as required 
(Figure 4). The ability to scale the J-couplings to varying extents 
means that the experiment can be tuned to the requirements of 
the sample and which metabolites are present, and of interest. 
Large expansion of J-coupling allows for rapid collection of data, 
as the resolution required to resolve them becomes diminished. 
However, this should be tempered by the need to avoid unnec-
essary overlap of signals. To date, the authors have acquired 2D 
spectra with 8-fold enhanced 13C J-couplings, combined with 
shortening the acquisition by using variable pulse sequence rep-
etition times28, leading to an overall decrease in acquisition time 
by a factor larger than 10 (i.e. an acquisition time of 22 minutes 
compared to 4 hours for normal NUS acquisition). This can be 
stretched to even shorter acquisition times by including spectral 
folding in the acquisition protocol. Figure 4 demonstrates the 
effect of J-scaling on 2D HSQC spectra, displaying C(6) of 13C 
enriched glucose. The trace through the left-most signal, displayed 
in panel D, demonstrates clearly that while the singlet in the mid-
dle of the multiplet does not change, the apparent 1JCC constant 
increases and in fact splits into multiple signals as previously 
unresolved long-range couplings are amplified so that they are 
large enough to become resolved in the spectrum.
Figure 3. J-Coupling Enhanced HSQC. The J-coupling enhancement is achieved using an additional spin echo subsequent to the 13C 
evolution period. The delays in the spin-echo for the J-coupling enhancement are multiples of the dwell time (dw). While the chemical shift 
evolves with dw, which is determined by setting the spectral width of the spectrum, J-coupling is enhanced depending on the increment of 
the 13C gradient selection spin-echo. The HSQC is acquired using echo-antiecho for quadrature detection to allow for efficient removal of 
artefacts in only two scans per increment. Optionally the 13C,15N-couplings can be scaled by the introduction of the 15N π-pulse parallel to the 
grey 13C π-pulse, also shown in grey. The pulse phases are: φ1 = y; φ2 = x, -x; φrec = x, -x.
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Figure 4. J-coupling enhancement HSQC. The spectrum with no J-coupling enhancement is shown in blue, with an enhancement of two in 
green and with an enhancement of four in red. The 13C trace of the HSQC clearly shows the increase in splitting. The J-coupling enhancement 
is achieved using an additional spin echo subsequent to the 13C evolution period. The delays in the J-scaling are multiples of dw such the use 
of a delay of 3*dw will result in a J-scaling of 4 (one from the t1 evolution and three from the J-scaling spin echo).
15N tracing
Biological methods. 2D 14N spectral filter - Sample prepara-
tion is described in 16. 2D 1H13C-HSQC NMR with and without 
14N filtering spectra were acquired using a Bruker Avance III 
600 MHz NMR spectrometer equipped with a 1.7mm z-PFG TCI 
Cryoprobe. The HSQC spectra were acquired using 2 transients 
per increment with echo/anti-echo gradient coherence selection 
and an additional pre-saturation for suppressing the water 
resonance during the 1.5s interscan relaxation delay. The 1H 
dimension was acquired with a spectral width of 13ppm using 512 
complex data points. The 13C dimension was acquired with a 
spectral width of 160 ppm using 2048 data points. The spec-
tra were processed with quadratic cosine window functions and 
without baseline correction to avoid complications in the multiplet 
analysis procedure.
13C,15N J-coupling enhancement. The human Medulloblastoma 
cell line DAOY from ATCC (HTB-186™) was used to investi-
gate the fate of both carbon and nitrogen from glutamine. The 
importance of glutamine in relation to cancer biology has been 
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exhausted in the literature, with numerous cancers being 
addicted to glutamine despite it being a non-essential amino acid. 
Glutamine serves as a vital metabolite to deliver both carbon 
and nitrogen for several cellular processes including growth and 
redox control. It is therefore important to track the flux of car-
bon and nitrogen from glutamine together, providing a more 
detailed account of this metabolite in tumour biology. One such 
metabolite that may require both carbon and nitrogen from 
glutamine is alanine. Alanine is typically synthesised from pyru-
vate by reductive amination, where an aminotransferase enzyme 
facilitates the addition of the amino group from glutamate to 
pyruvate.
3 x 106 cells were seeded onto 15 cm dishes and cultured in 
standard medium overnight. Basic formulation DMEM media 
(Sigma, D5030) was supplemented with 2 mM L-Glutamine-13C5, 
15N2(sigma, 607983) and 10mM of 13C6 glucose (Sigma, 389374) 
and subsequently added to cells for 24 h.
At the conclusion of tracer experiments, cells were washed 
with ice-cold saline solution (0.9%) and collected by scraping 
in 1.2 mL pre-chilled methanol (-20°C), 600µl water (4°C) and 
1.2 mL chloroform (-20°C). Cell lysates were vortexed for 15 min 
at 4°C and instantly centrifuged at 15,000 g for 15 min at 4°C.
Samples were dried using a Savant (SPD1010) speedvac con-
centrator and then resuspended in 60 µL of 100 mM sodium 
phosphate buffer containing 500 µM DSS and 2 mM Imidazole, 
10% D20, pH 7.0. Samples were vortexed, sonicated for 10min 
and centrifuged momentarily (these steps were repeated twice), 
prior to being manually transferred to 1.5ml NMR tubes.
2D 1H13C-HSQC and 2D 1H15N-HSQC NMR spectra were 
acquired using a Bruker Avance III 900 MHz NMR spectrometer 
equipped with a 5mm z-PFG TCI Cryoprobe. The HSQC spectra 
were acquired using 2 transients per increment with echo/anti- 
echo gradient coherence selection and with an additional 
pre-saturation for suppressing the water resonance during the 
1.5s interscan relaxation delay. The 1H dimension of the 
13C-HSQC was acquired with a spectral width of 12ppm using 
512 complex data points. The 13C dimension was acquired with a 
spectral width of 165 ppm using 30% (2458) of 8192 data points 
using a non-uniform sampling scheme. The 1H dimension of the 
15N-HSQC was acquired with a spectral width of 12 ppm using 
1024 complex data points. The 15N dimension was acquired with 
a spectral width of 40 ppm using 47.5% (122) of 256 data points 
using a non-uniform sampling scheme. All non-uniformly 
sampled spectra were reconstructed via the compressed sens-
ing algorithm within the MDDNMR (version 2.5)26 and proc-
essed using NMRpipe (version 9.2)27. All spectra were processed 
without baseline correction to avoid complications in the 
multiplet analysis procedure.
NMR methodology. Both aforementioned methods can be used 
to detect 15N labelling in metabolites, which alongside 13C isotope 
incorporation can provide additional much-needed information 
on the overlapping activity of multiple metabolic pathways. 2D 
spectroscopic filters are an extension of the 1D concept and as 
such can be used to simplify increasingly complex 2D spectra by 
selectively observing a subset of metabolites in which nuclei of 
interest have been incorporated. For example, the analysis of the 
13C nuclei that are adjacent to 15N nuclei using 2D spectra permits 
a simplified unequivocal description of the nature in which two 
metabolic pathways converge.
Similar to the 1D method, the acquisition of 2 spectra is required 
in order to enable a quantitative analysis of the amount of 15N 
labelling in the presence of 13C labelling within the metabo-
lite. If spectral simplification is the goal, a single spectrum is 
sufficient16. The pulse sequence (Figures 5) is a gradient selected 
2D-1H,13C HSQC spectrum with the spectral filter added once 
the 1H magnetisation has been transferred to the 13C nucleus. The 
spectrum collected with the 15N spectral filter (Figure 5) con-
tains only two visible NMR signals, corresponding to arginine 
and arginosuccinate, clearly showing how the filter can simplify 
complex spectra for easier analysis.
While 2D spectral filters serve a purpose, their quantitative usage 
is limited by the variability of the 1JCN constant. J-scaling on the 
other hand can be easily extended to include 13C-15N J-scal-
ing. Indeed, the addition of a single 15N π−pulse parallel to the 
grey shaded 13C π−pulse in Figure 3 is sufficient to upscale the 
apparent 13C-15N J-coupling constant in 2D-1H,13C HSQC spectra. 
An example is given in Figure 6. Panels C and D show traces 
of the 13C multiplets for carbon atoms 2 and 3 of alanine. While 
the JCC couplings are enhanced by a factor of 4 in both 
spectra, the apparent JCN couplings are unchanged in the amber 
spectrum, whereas they are enhanced by a factor of 2 in the 
blue spectra. Because the 2JCN coupling between C(3) and N is 
negligible, both traces for C(3) overlap perfectly. C(2) on the 
other hand experiences a 1JCN coupling, which leads to the much 
more complex blue spectrum. The 2D signals for the JCN scaled 
spectrum are shown in Figures 6A and B.
JCN coupling, as any J-coupling, works in two directions, there-
fore a similar approach can be followed from the opposite direc-
tion. While amine groups of small molecules are notoriously 
difficult to observe due to chemical exchange of amine protons 
with solvent molecules, a long-range HSQC can be acquired. In 
such a spectrum proton magnetisation is transferred from Hα (the 
proton bound to C(2)) via the 2JHN coupling. The JNC-coupling 
then can be enhanced to show the appearance of 13C labelling 
in molecules which contain 15N next to those labelled carbon 
nuclei. As in this case, where the 13C nucleus is also bound to the 
proton determining the chemical shift on the horizontal axis, 
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Figure 5. Filtered HSQC. Unfiltered (black) and filtered (amber) 2D-1H,13H HSQC spectra. In the filtered spectrum only carbon nuclei 
adjacent to 15N are visible. Similar to the filtered pulse sequence in Figure 1, the amber pulses are only executed in the 14N filtered pulse 
sequence and the grey 15N π-pulse is executed every second transient. The pulse phases are: φ1 = y; φ2 = x, -x; φ3 = x / y; φ4 = y, –y / y, y; 
φ5 = y, -y / x, -x; φ6 = x, x, -x, -x; φ7 = x, x, x, x, -x, -x, -x, -x; φ8 = x, x, x, x, y, y, y, y; φrec = x, -x, -x, x, y, -y, -y, y.
that same proton signal will be split by the 1JCH-coupling con-
stant. The result in this case is therefore a signal split into 4 2D 
components, demonstrating that alanine was either recycled 
from unlabelled alanine which was incorporated into proteins, or 
synthesised de-novo from [U-13C] glucose and 15N labelled 
glutamate which originated from [U-13C, U-15N] glutamine which 
was added to the growth medium in addition to the [U-13C] 
glucose. In conjunction with MS data, this complementarity 
between the 2D-1H,13C and the 2D-1H,15N HSQC spectra ena-
bles a model-free metabolism analysis using multiple nutrients as 
tracer source in a single sample.
All NMR spectra in this article were processed within the 
MetaboLab software package (version 1.0.0.1; http://metabolab.
uk)20. Details on sample preparation, data acquisition, processing 
and analysis are available in supporting information.
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Figure 6. Splitting due to 15N and 13C incorporation. Alanine regions of the 2D-1H,13C HSQC spectrum (A & B). The signals are split by either 
1JCC or 
1JCN coupling contributions. The long range 2D-
1H,15N HSQC (C) is composed of unlabelled alanine (middle peak) and 13C/15N labelled 
alanine (4 outer signals, split by 2JHN and 
1JNC couplings).
Discussion
Changes in metabolism are increasingly being recognised as 
central to the pathogenesis of a number of different diseases. 
Although metabolomic studies have helped determine aspects of 
disease phenotype, tracing the changing use of specific metabolic 
pathways using stable isotope-enriched nutrients provides higher 
resolution information on altered metabolic pathway activity 
that may lead to the identification of specific novel therapeutic 
targets. Over the last few years, development of magnet and 
probe technology, including innovative ultra-sensitive micro-
probes, has enabled the study of systems that were not previously 
amenable to NMR. Parallel advancement in the methods used to 
acquire and analyse data from samples will increase the amount 
of information we can gain from the such samples.
In this paper, we describe how spectral filters and J-splitting 
enhancement can be used in tracer based metabolism studies. 
These techniques overcome some of the major hurdles in the 
use of NMR spectroscopy. A challenge in the analysis of NMR 
HSQC data has been the need for an additional “unlabelled” 
sample in order to determine absolute per carbon 13C incorpora-
tion percentages. However, samples cannot be assumed to be 
biologically identical, thus making analyses problematic due 
to the inability to determine accurate 13C isotope incorporation 
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values. Systems that demonstrate greater inter-sample varia-
tion, such as in vivo tracer studies, are even more prone to these 
analytical issues. The use of spectral filters negates the require-
ment for two samples and instead a single sample can be used to 
determine absolute percentage 13C incorporation and thus allow 
the scaling of multiplets.
The 2D HSQC is a powerful tool in the study of metabo-
lism as it takes advantage of the increased sensitivity of the 1H 
nucleus over 13C and using the splitting due to J-coupling in the 
13C dimension allows the indirect visualisation of the 13C incorpo-
ration into quaternary carbons. However, long acquisitions times, 
even when using the latest NUS techniques, limits the number 
of samples that can be acquired. Reducing the experimental time 
makes the use of HSQCs a much more attractive method in the 
study of tracer based metabolism. The use of echo-antiecho for 
quadrature detection ensures efficient elimination of unwanted 
artefacts whilst using only 2 scans per increment in the indirect 
dimension. The changes observed in lineshape due to the quad-
rature detection are predictable and can be easily incorporated 
into line fitting analysis. The spin echo required for the echo- 
antiecho can further be utilised to enhance the observed splitting 
due to J-coupling.
The ability to scale the visualised J-couplings allows HSQC 
spectra to be acquired in time equivalent to that by 1D spectra but 
the HSQC contains significantly more information. The reduced 
time required to acquire spectra mean that it is feasible to apply 
2D HSQC methods to in vivo tracer based metabolism studies, 
as well as allowing the use of greater sensitivity of higher field 
spectrometers while avoiding longer experiment times. Expand-
ing the splitting due to J-coupling can also bring out smaller 
long-range couplings that were not apparent in a normal HSQC. 
Thus, the J-scale can either be used to decrease acquisition times 
by allowing data collection at lower resolution or to bring out 
smaller couplings not previously visible. These small couplings 
include the 1JCN couplings that are found in many metabolites 
after the addition of metabolites labelled 15N in conjugation with 
13C. This increases the information available and allows more 
in-depth analysis of complex metabolic pathways. In the exam-
ple shown (Figure 5), the cells used for this experiment lacked 
the expression of fumarate hydratase16 and therefore contained 
high fumarate levels. One hypothesis was that the cells form 
argininosuccinate from fumarate and arginine to minimise intra-
cellular fumarate. In order to ascertain the signal assignment, 
we used [U-13C, U-15N] arginine and were able to show that 
15N labelled argininosuccinate was being formed in the cells 
containing the knock out, while wild-type cells did not produce 
15N labelled argininosuccinate16. This shows the utility of using 
multiple labelled nutrients to answer fundamental questions in 
metabolism.
In summary, the spectroscopic tools presented here open up 
new avenues for tracer based metabolism studies. Scaling of 
J-coupling constants leads to faster data collection of samples 
supplemented with nutrients enriched in stable isotopes, such as 
13C and 15N. This enables profiling of metabolic pathways and 
can also be used to enhance sensitivity beyond current technical 
developments whilst maintaining reasonable data acquisition 
times. Ultimately, use of the 1D spectral filters as well as the 
fast acquisition of HSQC spectra leads to the possibility of trac-
ing metabolism in real-time. In addition, simultaneous tracing 
with multiple nutrients will lead to unprecedented insight into the 
interplay of converging and intersecting metabolic pathways, both 
in vitro and in vivo29.
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